119 related articles for article (PubMed ID: 38148147)
1. Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS).
Mehta P; Samanta RJ; Wick K; Coll RC; Mawhinney T; McAleavey PG; Boyle AJ; Conlon J; Shankar-Hari M; Rogers A; Calfee CS; Matthay MA; Summers C; Chambers RC; McAuley DF; O'Kane CM
Thorax; 2024 Feb; 79(3):227-235. PubMed ID: 38148147
[TBL] [Abstract][Full Text] [Related]
2. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
Calfee CS; Delucchi KL; Sinha P; Matthay MA; Hackett J; Shankar-Hari M; McDowell C; Laffey JG; O'Kane CM; McAuley DF;
Lancet Respir Med; 2018 Sep; 6(9):691-698. PubMed ID: 30078618
[TBL] [Abstract][Full Text] [Related]
3. Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.
Moore AR; Pienkos SM; Sinha P; Guan J; O'Kane CM; Levitt JE; Wilson JG; Shankar-Hari M; Matthay MA; Calfee CS; Baron RM; McAuley DF; Rogers AJ
Crit Care Med; 2023 Dec; 51(12):e269-e274. PubMed ID: 37695136
[TBL] [Abstract][Full Text] [Related]
4. Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials.
Pienkos SM; Moore AR; Guan J; Levitt JE; Matthay MA; Baron RM; Conlon J; McAuley DF; O'Kane CM; Rogers AJ
Crit Care; 2023 Mar; 27(1):126. PubMed ID: 36978134
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
Santhakumaran S; Gordon A; Prevost AT; O'Kane C; McAuley DF; Shankar-Hari M
Crit Care; 2019 May; 23(1):156. PubMed ID: 31053084
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
Sinha P; Calfee CS; Cherian S; Brealey D; Cutler S; King C; Killick C; Richards O; Cheema Y; Bailey C; Reddy K; Delucchi KL; Shankar-Hari M; Gordon AC; Shyamsundar M; O'Kane CM; McAuley DF; Szakmany T
Lancet Respir Med; 2020 Dec; 8(12):1209-1218. PubMed ID: 32861275
[TBL] [Abstract][Full Text] [Related]
7. Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial.
Boyle AJ; Ferris P; Bradbury I; Conlon J; Shankar-Hari M; Rogers AJ; O'Kane CM; McAuley DF
Crit Care; 2022 Jun; 26(1):164. PubMed ID: 35672834
[TBL] [Abstract][Full Text] [Related]
8. Subphenotypes in patients with acute respiratory distress syndrome treated with high-flow oxygen.
Blot PL; Chousterman BG; Santafè M; Cartailler J; Pacheco A; Magret M; Masclans JR; Artigas A; Roca O; García-de-Acilu M
Crit Care; 2023 Nov; 27(1):419. PubMed ID: 37915062
[TBL] [Abstract][Full Text] [Related]
9. Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies.
Verghis RM; McDowell C; Blackwood B; Lee B; McAuley DF; Clarke M
Trials; 2023 Mar; 24(1):183. PubMed ID: 36907882
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials.
Sinha P; Delucchi KL; McAuley DF; O'Kane CM; Matthay MA; Calfee CS
Lancet Respir Med; 2020 Mar; 8(3):247-257. PubMed ID: 31948926
[TBL] [Abstract][Full Text] [Related]
11. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
Calfee CS; Delucchi K; Parsons PE; Thompson BT; Ware LB; Matthay MA;
Lancet Respir Med; 2014 Aug; 2(8):611-20. PubMed ID: 24853585
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin in the acute respiratory distress syndrome.
McAuley DF; Laffey JG; O'Kane CM; Perkins GD; Mullan B; Trinder TJ; Johnston P; Hopkins PA; Johnston AJ; McDowell C; McNally C; ;
N Engl J Med; 2014 Oct; 371(18):1695-703. PubMed ID: 25268516
[TBL] [Abstract][Full Text] [Related]
13. The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial.
McKelvey MC; Bradbury I; McDowell C; Calfee CS; Weldon S; O'Kane CM; McAuley DF; Taggart CC
Crit Care Resusc; 2022 Sep; 24(3):251-258. PubMed ID: 38046206
[No Abstract] [Full Text] [Related]
14. Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study.
Sinha P; Delucchi KL; Chen Y; Zhuo H; Abbott J; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Calfee CS
Thorax; 2022 Jan; 77(1):13-21. PubMed ID: 34253679
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Outcomes, and Predictors of Subphenotypes of Acute Kidney Injury among Acute Respiratory Distress Syndrome Patients: A Prospective Observational Study.
Todur P; Nileshwar A; Chaudhuri S; Srinivas T
Indian J Crit Care Med; 2023 Oct; 27(10):724-731. PubMed ID: 37908431
[TBL] [Abstract][Full Text] [Related]
16. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
17. Predicting Acute Respiratory Distress Syndrome in Severe Blunt Trauma: The Utility of Interleukin-18.
Beattie G; Cohan CM; Victorino GP
Surg Infect (Larchmt); 2021 Nov; 22(9):948-954. PubMed ID: 33983849
[No Abstract] [Full Text] [Related]
18. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
[TBL] [Abstract][Full Text] [Related]
19. [Statin in the treatment of ALI/ARDS: a systematic review and Meta-analysis based on international databases].
Chen M; Lu J; Chen Q; Cheng L; Geng Y; Jiang H; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):51-56. PubMed ID: 28459404
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
